Lazard Asset Management’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.06M Buy
197,682
+28,154
+17% +$1.15M 0.01% 475
2026
Q2
$7.1M Buy
169,528
+22,026
+15% +$853K 0.01% 518
2026
Q1
$5.55M Sell
147,502
-20,229
-12% -$661K 0.01% 536
2025
Q4
$5.05M Sell
167,731
-83,110
-33% -$2.35M 0.01% 553
2025
Q3
$6.58M Sell
250,841
-45,818
-15% -$1.09M 0.01% 508
2025
Q2
$6.32M Buy
296,659
+103,146
+53% +$2.33M 0.01% 670
2025
Q1
$4.11M Buy
193,513
+2,716
+1% +$55.7K 0.01% 740
2024
Q4
$3.86M Buy
190,797
+860
+0.5% +$17.8K 0.01% 701
2024
Q3
$3.19M Buy
+189,937
New +$3.2M ﹤0.01% 750

Other funds holding GRDN

Lazard Asset Management's GRDN Position: Q3 2026 in Review

Lazard Asset Management increased its Guardian Pharmacy Services (GRDN) stake by 17% in Q3 2026, buying an estimated $1.15M and bringing the position to 197,682 shares worth $8.06M. The position accounts for 0.01% of the portfolio, ranked #475.

Lazard Asset Management first reported a position in GRDN in Q3 2024 and has held it in 9 quarters since. 196 funds tracked by Wall St. Rank hold GRDN as of Q3 2026.

  • Lazard Asset Management held 197,682 shares of Guardian Pharmacy Services worth $8.06M as of Q3 2026.
  • Lazard Asset Management bought 28,154 Guardian Pharmacy Services shares in Q3 2026, an estimated $1.15M.
  • Guardian Pharmacy Services made up 0.01% of Lazard Asset Management's portfolio in Q3 2026, its #475 holding.
  • Lazard Asset Management first reported a position in Guardian Pharmacy Services in Q3 2024 and has held it in 9 quarters since.
  • 196 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q3 2026.

Based on Lazard Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.